Element Materials Technology acquires clinical testing firm Clinimark

  • Element Materials Technology acquired Clinimark on April 21, 2022, adding clinical FDA validation testing for vital-sign data used in medical and consumer wearables.
  • Clinimark, based in Louisville, Colorado, specializes in clinical validation of pulse oximetry and invasive and non-invasive blood pressure measurements.
  • The deal expands Element’s connected technologies and life sciences offering into clinical testing, supporting product development through regulatory submissions across the US, Europe, and Asia.
  • Clinimark also validates other vital-sign areas, including respiratory rate, heart function, and sleep apnea, broadening Element’s testing capabilities.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Element Ventures published the original content used to generate this news brief on June 03, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.